Monitoring serum HER2 levels during neoadjuvant trastuzumab treatment within the GeparQuattro trial. (Record no. 19966279)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 02076 a2200613 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250515232058.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 201012s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1573-7217 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1007/s10549-010-1030-9 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Witzel, Isabell |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20101208 |
245 00 - TITLE STATEMENT | |
Title | Monitoring serum HER2 levels during neoadjuvant trastuzumab treatment within the GeparQuattro trial. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | Breast cancer research and treatment |
Date of publication, distribution, etc. | Sep 2010 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 437-45 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antibodies, Monoclonal |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antibodies, Monoclonal, Humanized |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antineoplastic Agents |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Biomarkers, Tumor |
General subdivision | blood |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Breast Neoplasms |
General subdivision | blood |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Chemotherapy, Adjuvant |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Enzyme-Linked Immunosorbent Assay |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Female |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Germany |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Middle Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Neoadjuvant Therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Neoplasm Staging |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Odds Ratio |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Receptor, ErbB-2 |
General subdivision | antagonists & inhibitors |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Time Factors |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Trastuzumab |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Treatment Outcome |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Loibl, Sibylle |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | von Minckwitz, Gunter |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Mundhenke, Christoph |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Huober, Jens |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Hanusch, Claus |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Henschen, Stephan |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Hauschild, Maik |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Lantzsch, Tilmann |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Tesch, Hans |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Latos, Kunibert |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Just, Marianne |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Hilfrich, Jörn |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Barinoff, Jana |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Eulenburg, Christine Zu |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Roller, Marc |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Untch, Michael |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Müller, Volkmar |
773 0# - HOST ITEM ENTRY | |
Title | Breast cancer research and treatment |
Related parts | vol. 123 |
-- | no. 2 |
-- | p. 437-45 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1007/s10549-010-1030-9">https://doi.org/10.1007/s10549-010-1030-9</a> |
Public note | Available from publisher's website |
No items available.